Header cover image

Pharmaceuticals & Biotech Recent Global IPOs

Results

2

0 new
Behind flashy headliners, a handful of newly listed companies quietly become the best investments nobody was watching. This screener tracks companies that have listed in the past 6 months across 31 global markets and present solid financial health and future projections at a well priced value.

2 companies

Ascendis Pharma

Market Cap: US$16.6b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

ASND

US$251.07

7D

-0.6%

1Y

n/a

Apotex Health

Market Cap: CA$8.3b

Operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.

APTX

CA$37.50

7D

4.3%

1Y

n/a